Ceasovschih Alexandr: A New Perspective on Allergic Cardiac Events Driven by Host Factors
Ceasovschih Alexandr, Assistant Professor at Grigore T. Popa University of Medicine and Pharmacy Section, Editor at Archives of Medical Science, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Medical Sciences, adding:
“Just published!
Kounis syndrome is not just an allergic reaction, it is a patient-dependent cardiovascular response.
Our latest review explores how host factors (age, comorbidities, immune status, and vascular substrate) shape clinical presentation and outcomes across special populations, and proposes a host-modified framework that complements the classical Type I/II/III classification, with potential implications for risk stratification and personalized care.
A special thank you to Professor Nicholas Kounis himself and to all co-authors for this collaborative effort.”
Title: Kounis Syndrome Features in Special Populations
Authors: Alexandr Ceasovschih, Nicholas G. Kounis, Sura Markos, Malik Ejubovic, Maria Cherska, Fotios Barkas, Vladimir Ristovski, Alexandru Corlateanu, Pradeesh Sivapalan, Stanislav Kotlyarov, Victorita Sorodoc, Laurentiu Sorodoc

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian